Vermillion Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.2K Hold
365
0.01% 560
2026
Q1
$55.8K Hold
365
0.02% 194
2025
Q4
$50.3K Hold
365
0.02% 197
2025
Q3
$46.8K Hold
365
0.01% 608
2025
Q2
$44.2K Sell
365
-100
-22% -$11.3K 0.02% 189
2025
Q1
$51.8K Hold
465
0.02% 503
2024
Q4
$45.2K Buy
+465
New +$49.6K 0.02% 188

Other funds holding NVS

Vermillion Wealth Management's NVS Position: Q2 2026 in Review

Vermillion Wealth Management held its Novartis (NVS) position steady in Q2 2026 at 365 shares worth $57.2K. The position accounts for 0.01% of the portfolio, ranked #560.

Vermillion Wealth Management first reported a position in NVS in Q4 2024 and has held it in 7 quarters since. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Vermillion Wealth Management held 365 shares of Novartis worth $57.2K as of Q2 2026.
  • Vermillion Wealth Management left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.01% of Vermillion Wealth Management's portfolio in Q2 2026, its #560 holding.
  • Vermillion Wealth Management first reported a position in Novartis in Q4 2024 and has held it in 7 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.